📜 iter-4360dd15-0022.log
31921 bytes
# Iter-0022 mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-25T23:28:39
# focus_node: n127 :: 筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选
========== TRANSCRIPT ==========
→ call task_view({"max_depth":6})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n► [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call task_current({})
【tool:task_current】
{"ok": true, "id": "root", "title": "找到让人类长生不老的方法", "rationale": "总目标", "status": "done", "result": "完成了对体外/器官类系统的顺序实验补充检索，未发现 senolytic 预处理后再做 OSK/partial reprogramming 的原始研究，证据缺口进一步扩大到 ex vivo 体系。", "path": ["找到让人类长生不老的方法"], "children": [{"id": "n1", "title": "建立 marker 锚定后的局部交换判定框架", "status": "done"}, {"id": "n2", "title": "证明左侧一次相邻交换的切分判定引理", "status": "done"}, {"id": "n3", "title": "刻画交换不依赖右侧的 witness 规范化条件", "status": "done"}, {"id": "n4", "title": "沉淀可复用的 predicate verification 方法论", "status": "done"}, {"id": "n15", "title": "凝练 marker 锚定局部交换框架为统一定理与检查协议", "status": "done"}, {"id": "n30", "title": "识别人类寿命上限的首要生物学瓶颈并提出可检验干预假设", "status": "done"}, {"id": "n36", "title": "比较并筛选第二个可检验的长寿瓶颈候选", "status": "done"}, {"id": "n37", "title": "用统一因果干预与安全读出比较表观遗传信息损失与细胞衰老", "status": "done"}, {"id": "n38", "title": "证伪视网膜 OSK 证据可作为长寿主路线的代表性：找同组织同读出头对头比较", "status": "done"}, {"id": "n39", "title": "锁定一个组织内的 OSK vs senolytic 同组织同终点证据地图", "status": "done"}, {"id": "n40", "title": "检索皮肤中 OSK vs senolytic 的原始头对头证据", "status": "done"}, {"id": "n44", "title": "寻找另一种组织中的 OSK vs senolytic 直接 head-to-head 原始证据", "status": "failed"}, {"id": "n45", "title": "定义 OSK vs senolytic 的最小可比实验规格", "status": "done"}, {"id": "n46", "title": "设计路由匹配的皮肤 OSK vs ABT-263 对照实验", "status": "done"}, {"id": "n47", "title": "把皮肤 OSK vs ABT-263 蓝图收敛成可执行参数表并做反证式审稿", "status": "done"}, {"id": "n52", "title": "补全皮肤 ABT-263 原始研究的精确参数并与 OSK 对齐", "status": "done"}, {"id": "n53", "title": "补齐皮肤 ABT-263 原始研究准确题名与完整参数", "
→ call task_view({"max_depth":10})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n► [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call search_memory({"limit":8,"mission_only":true,"query":"IL-11 next question senolytic OSK lifespan healthspan adult mouse gap"})
【tool:search_memory】
{"ok": true, "results": [{"title": "relevance-drifting: 把下一轮硬拉回到：IL-11 抑制是否能在成年哺乳动物中同时改善衰老相关多器官纤维化并带来可测的寿命/健康寿命收益。", "tags": "iteration relevance-check drifting", "mission": "4360dd15", "modified": "20260425151756000", "preview": "!! 目标相关性校准（drifting） verdict: **drifting** reason: 当前焦点仍围绕抗纤维化干预的安全性与修复代价，和“延长健康寿命/寻找长生不老方法”仍有关联，但已经转到非常窄的单一机制验证问题，离最终目标至少隔着一层到两层应用推演。 anchor_title: NEXT_FOCUS rebase_focus: 把下一轮硬拉回到：IL-11 抑制是否能在成年哺乳动物中同时改善衰老相关多器官纤维化并带来可测的寿命/健康寿命收益。 !! 被检查的 NEXT_FOCUS !! 下轮焦点（来自 mission `4360dd15` · Iter-0019） 转向核查 IL-11 抑制是否存在成人哺乳动物的肝脏、心脏或肺纤维化修复代价。 !! 被参考的最近标题 - NEXT_FOCUS"}, {"title": "NEXT_FOCUS-drifted-4360dd15-20260425-231756", "tags": "archive focus drift", "mission": "4360dd15", "modified": "20260425151756000", "preview": "!! 已归档的跑偏 NEXT_FOCUS verdict: drifting reason: 当前焦点仍围绕抗纤维化干预的安全性与修复代价，和“延长健康寿命/寻找长生不老方法”仍有关联，但已经转到非常窄的单一机制验证问题，离最终目标至少隔着一层到两层应用推演。 ──── 原内容 ──── !! 下轮焦点（来自 mission `4360dd15` · Iter-0019） 转向核查 IL-11 抑制是否存在成人哺乳动物的肝脏、心脏或肺纤维化修复代价。"}, {"title": "NEXT_FOCUS-archived-4360dd15-20260425-214810", "tags": "archive focus", "mission": "4360dd15", "modified": "20260425134810000", "preview": "!! 已归档的 NEXT_FOCUS（来自 mission `4360dd15`） !! 下轮焦点（来自 mission `4360dd15` · Iter-0120） [n82] 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选（路径：找到让人类长生不老的方法 > 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选）"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率；在某些组织里，senescence/
→ call search_memory({"limit":10,"mission_only":true,"query":"proteostasis mitochondria autophagy next bottleneck aging candidate evidence"})
【tool:search_memory】
{"ok": true, "results": [{"title": "NEXT_FOCUS-archived-4360dd15-20260425-214810", "tags": "archive focus", "mission": "4360dd15", "modified": "20260425134810000", "preview": "!! 已归档的 NEXT_FOCUS（来自 mission `4360dd15`） !! 下轮焦点（来自 mission `4360dd15` · Iter-0120） [n82] 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选（路径：找到让人类长生不老的方法 > 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选）"}, {"title": "NEXT_FOCUS-drifted-4360dd15-20260425-231756", "tags": "archive focus drift", "mission": "4360dd15", "modified": "20260425151756000", "preview": "!! 已归档的跑偏 NEXT_FOCUS verdict: drifting reason: 当前焦点仍围绕抗纤维化干预的安全性与修复代价，和“延长健康寿命/寻找长生不老方法”仍有关联，但已经转到非常窄的单一机制验证问题，离最终目标至少隔着一层到两层应用推演。 ──── 原内容 ──── !! 下轮焦点（来自 mission `4360dd15` · Iter-0019） 转向核查 IL-11 抑制是否存在成人哺乳动物的肝脏、心脏或肺纤维化修复代价。"}, {"title": "relevance-drifting: 把下一轮硬拉回到：IL-11 抑制是否能在成年哺乳动物中同时改善衰老相关多器官纤维化并带来可测的寿命/健康寿命收益。", "tags": "iteration relevance-check drifting", "mission": "4360dd15", "modified": "20260425151756000", "preview": "!! 目标相关性校准（drifting） verdict: **drifting** reason: 当前焦点仍围绕抗纤维化干预的安全性与修复代价，和“延长健康寿命/寻找长生不老方法”仍有关联，但已经转到非常窄的单一机制验证问题，离最终目标至少隔着一层到两层应用推演。 anchor_title: NEXT_FOCUS rebase_focus: 把下一轮硬拉回到：IL-11 抑制是否能在成年哺乳动物中同时改善衰老相关多器官纤维化并带来可测的寿命/健康寿命收益。 !! 被检查的 NEXT_FOCUS !! 下轮焦点（来自 mission `4360dd15` · Iter-0019） 转向核查 IL-11 抑制是否存在成人哺乳动物的肝脏、心脏或肺纤维化修复代价。 !! 被参考的最近标题 - NEXT_FOCUS"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率；在某些组织里，senescence/
→ call task_add({"parent_id":"root","rationale":"IL-11/炎症线索已推进到寿命终点，下一步应并行验证是否还存在能同时触达健康寿命与广谱组织稳态的第三类上游瓶颈；蛋白稳态/自噬是典型候选。","title":"筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选"})
→ call search_memory({"limit":8,"mission_only":true,"query":"autophagy proteostasis mitochondria lifespan healthspan bottleneck candidate"})
→ call search_memory({"limit":8,"mission_only":true,"query":"寿命终点 优先 通路 热度 自噬 线粒体 长寿 候选"})
【tool:task_add】
{"ok": true, "id": "n127", "parent": "root", "title": "筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选", "status": "pending"}
【tool:search_memory】
{"ok": true, "results": []}
【tool:search_memory】
{"ok": true, "results": [{"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时，应把“是否直接延长寿命/健康寿命”作为高优先级门槛，而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点，才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425050740000", "preview": "筛选长寿瓶颈时，不要把“看起来更上游”当作高杠杆的充分条件；真正更值得优先的靶点，是那些被扰动后能同时恢复多个下游功能、并最好有健康寿命或寿命终点支持的节点。"}, {"title": "免疫长寿入口的上游性排序", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425050322000", "preview": "在比较免疫相关长寿候选时，优先按因果上游性排序：补给源恢复 > 外周质量控制 > 局部 niche 维护。越接近补给源，越可能影响系统级健康寿命；只改善外周读出或局部环境，通常仍应视为下游入口而非最终瓶颈。"}, {"title": "先证终点，再谈长寿", "tags": "lesson endpoint-classification citation-chain trial-audit", "mission": "4360dd15", "modified": "20260424204906000", "preview": "综述只用于定位试验；真正的证据必须落到单个 PMID 的主要终点是否直接是死亡、生存、健康寿命或失能自由生存。"}, {"title": "先锁原始试验再谈长寿终点", "tags": "lesson classification endpoint citation-chain", "mission": "4360dd15", "modified": "20260424203542000", "preview": "从综述引用链先找未审计的原始人类试验，再只看死亡/生存/健康寿命/失能自由生存这类直接终点，避免被疾病量表或PFS误导。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境；PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "NEXT_FOCUS-archived-4360dd15-20260425-214810", "tags": "archive focus", "mission": "4360dd1
→ call task_focus({"id":"n127"})
【tool:task_focus】
{"ok": true, "focused": "n127", "title": "筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选", "status": "in_progress", "path": ["找到让人类长生不老的方法", "筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选"]}
→ call pubmed_search({"limit":5,"query":"mTOR rapamycin lifespan mice healthspan original study"})
→ call pubmed_search({"limit":5,"query":"autophagy aging mice lifespan original study"})
→ call pubmed_search({"limit":5,"query":"mitochondrial dysfunction aging mice lifespan original study"})
→ call web_search({"limit":5,"query":"rapamycin lifespan mice original study healthspan PMID"})
【tool:pubmed_search】
{"ok": true, "query": "mTOR rapamycin lifespan mice healthspan original study", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "autophagy aging mice lifespan original study", "results": [{"pmid": "37261264", "title": "Trends of mitochondrial changes in AD: a bibliometric study.", "source": "Front Aging Neurosci", "pubdate": "2023", "authors": ["Song R", "Guo Y", "Fu Y", "Ren H", "Wang H", "Yan H", "Ge Y"], "url": "https://pubmed.ncbi.nlm.nih.gov/37261264/"}]}
【tool:pubmed_search】
{"ok": true, "query": "mitochondrial dysfunction aging mice lifespan original study", "results": [{"pmid": "37261264", "title": "Trends of mitochondrial changes in AD: a bibliometric study.", "source": "Front Aging Neurosci", "pubdate": "2023", "authors": ["Song R", "Guo Y", "Fu Y", "Ren H", "Wang H", "Yan H", "Ge Y"], "url": "https://pubmed.ncbi.nlm.nih.gov/37261264/"}, {"pmid": "21151927", "title": "Stressed-induced TMEM135 protein is part of a conserved genetic network involved in fat storage and longevity regulation in Caenorhabditis elegans.", "source": "PLoS One", "pubdate": "2010 Dec 3", "authors": ["Exil VJ", "Silva Avila D", "Benedetto A", "Exil EA", "Adams MR", "Au C", "Aschner M"], "url": "https://pubmed.ncbi.nlm.nih.gov/21151927/"}]}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call pubmed_search({"limit":10,"query":"rapamycin extends lifespan mice Harrison PubMed"})
→ call pubmed_search({"limit":10,"query":"rapamycin healthspan mice original PMID longevity"})
→ call pubmed_search({"limit":10,"query":"autophagy induction lifespan mice original PMID"})
→ call pubmed_search({"limit":10,"query":"mitochondrial quality control lifespan mice original PMID"})
【tool:pubmed_search】
{"ok": true, "query": "rapamycin extends lifespan mice Harrison PubMed", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "rapamycin healthspan mice original PMID longevity", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "autophagy induction lifespan mice original PMID", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "mitochondrial quality control lifespan mice original PMID", "results": []}
→ call search_memory({"limit":10,"mission_only":true,"query":"rapamycin lifespan mice healthspan"})
→ call search_memory({"limit":10,"mission_only":true,"query":"autophagy lifespan healthspan mice"})
→ call search_memory({"limit":10,"mission_only":true,"query":"mitochondria longevity mice lifespan"})
【tool:search_memory】
{"ok": true, "results": [{"title": "先抓人类试验证据表", "tags": "lesson evidence human-trials rapamycin", "mission": "4360dd15", "modified": "20260424173558000", "preview": "先锁定一篇高质量综述，再反向提取其纳入的人类试验、终点和不良反应。"}, {"title": "先拿到可访问全文表格", "tags": "lesson [[evidence retrieval]] human-trials rapamycin", "mission": "4360dd15", "modified": "20260424180508000", "preview": "遇到综述型任务时，先锁定可访问的全文/镜像/补充表格，再从Table 1反推试验名单，不要先猜题。"}, {"title": "先用可访问综述骨架锁定缺口", "tags": "lesson [[evidence retrieval]] human-trials rapamycin", "mission": "4360dd15", "modified": "20260424175843000", "preview": "优先从能访问的综述表格提取已知条目和缺口，再针对缺口做定点检索。"}, {"title": "先找可访问的二级证据入口", "tags": "lesson [[evidence retrieval]] rapamycin human-trials", "mission": "4360dd15", "modified": "20260424180750000", "preview": "遇到付费墙时，优先用Europe PMC、PubMed元数据或可检索摘要重建表格，而不是持续硬闯全文。"}, {"title": "先用可访问综述骨架再补缺项", "tags": "lesson [[evidence retrieval]] human-trials rapamycin", "mission": "4360dd15", "modified": "20260424175603000", "preview": "遇到付费墙时，先用摘要/检索片段/可访问表格建立完整骨架，再逐项回填缺失试验。"}, {"title": "先把异质证据拆成逐试验清单", "tags": "lesson evidence human-trials rapamycin", "mission": "4360dd15", "modified": "20260424174404000", "preview": "对抗“有效”叙事时，先把不同药物、不同人群、不同终点的研究拆成逐项清单，再讨论总体结论。"}, {"title": "先锁定综述正文里的表，再追原始试验", "tags": "lesson [[evidence retrieval]] human-trials rapamycin", "mission": "4360dd15", "modified": "20260424175236000", "preview": "遇到“补全纳入研究”问题时，先从综述的表格/补充材料抽取研究名和终点，再回查原始试验。"}, {"title": "先用可访问入口锁定表格", "tags": "lesson [[evidence retrieval]] rapamycin h
【tool:search_memory】
{"ok": true, "results": []}
【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开，再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境；PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述，先从参考文献中抽取一个未审计的原始人类试验 PMID，再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}]}
→ call web_search({"limit":8,"query":"rapamycin extends lifespan mice PMID Nature 2009 Harrison"})
→ call web_search({"limit":8,"query":"autophagy longevity mice original study PMID rapamycin"})
→ call web_search({"limit":8,"query":"mTOR inhibition healthspan lifespan mice original study PMID"})
【tool:web_search】
{"ok": false, "error": "timed out"}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call pubmed_search({"limit":10,"query":"Harrison rapamycin prolongs lifespan mice PMID"})
→ call pubmed_search({"limit":10,"query":"mTOR inhibitor extends lifespan mice Harrison 2009"})
→ call pubmed_search({"limit":10,"query":"rapamycin aging mice longevity"})
→ call pubmed_search({"limit":10,"query":"sirolimus lifespan mice original study"})
【tool:pubmed_search】
{"ok": true, "query": "Harrison rapamycin prolongs lifespan mice PMID", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "mTOR inhibitor extends lifespan mice Harrison 2009", "results": [{"pmid": "19587680", "title": "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.", "source": "Nature", "pubdate": "2009 Jul 16", "authors": ["Harrison DE", "Strong R", "Sharp ZD", "Nelson JF", "Astle CM", "Flurkey K", "Nadon NL", "Wilkinson JE"], "url": "https://pubmed.ncbi.nlm.nih.gov/19587680/"}]}
【tool:pubmed_search】
{"ok": true, "query": "rapamycin aging mice longevity", "results": [{"pmid": "42011226", "title": "SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways.", "source": "Drug Des Devel Ther", "pubdate": "2026", "authors": ["Weiss B", "Miranda DR", "Arrazati D", "Cao R", "Chen J", "Liu Y", "Brown D", "Marshall G"], "url": "https://pubmed.ncbi.nlm.nih.gov/42011226/"}, {"pmid": "41979886", "title": "Hyperactive Muscle mTORC1 Attenuates Functional Adaptations to Endurance Training Despite Alterations in Mitochondrial and Lipid Profiles.", "source": "J Appl Physiol (1985)", "pubdate": "2026 Apr 14", "authors": ["Kalenta H", "Marchant ED", "Kilroe SP", "Maroto R", "May JT", "Bugay V", "Romsdahl TB", "Linares JJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/41979886/"}, {"pmid": "41863332", "title": "Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice.", "source": "J Gerontol A Biol Sci Med Sci", "pubdate": "2026 Mar 21", "authors": ["Singh R", "Calderon VE", "Deborah H", "Diaz V", "Martinez PA", "Galvan V", "Javors M", "Fernandez E"], "url": "https://pubmed.ncbi.nlm.nih.gov/41863332/"}, {"pmid": "41653162", "title": "Rapamycin Reverses the Hepatic Response to Diet-Induced Metabolic Stress That Is Amplified by Aging.", "source": "Aging Cell", "pubdate": "2026 Feb", "authors": ["Havas A", "Rajesh A", "Lei X", "Proulx J", "Miller KN", "Field A", "Davis A", "Teneche MG"], "url": "https://pub
【tool:pubmed_search】
{"ok": true, "query": "sirolimus lifespan mice original study", "results": [{"pmid": "27312235", "title": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.", "source": "Aging Cell", "pubdate": "2016 Oct", "authors": ["Strong R", "Miller RA", "Antebi A", "Astle CM", "Bogue M", "Denzel MS", "Fernandez E", "Flurkey K"], "url": "https://pubmed.ncbi.nlm.nih.gov/27312235/"}]}
→ call web_fetch({"max_chars":5000,"url":"https://pubmed.ncbi.nlm.nih.gov/19587680/"})
【tool:web_fetch】
{"ok": true, "url": "https://pubmed.ncbi.nlm.nih.gov/19587680/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content An official website of the United States government Here's how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Log in Show account info Close Account Logged in as: username Dashboard Publications Account settings Log out Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard User Guide Save Email Send to Clipboard My Bibliography Collections Citation manager Display options Display options Format Abstract PubMed PMID Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel Email citation Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel Add to Collections Create a new collection Add to an
→ call write_note({"tags":["fact","lesson","principle","aging","triage"],"text":"!! 以寿命终点筛第三个长寿瓶颈时，mTOR/rapamycin 优先于泛化的自噬/线粒体口号\n''结论'': 当候选还停留在“看起来很基础、很上游”的层面时，不要把自噬或线粒体这类宽泛概念自动升格为长寿瓶颈；优先级应给到已经有''成年哺乳动物寿命终点''支持的具体节点。一个典型例子是 rapamycin / mTOR 抑制：PMID 19587680（Nature 2009）直接报告了晚期给药仍可延长遗传异质小鼠寿命。\n\n''判定规则'':\n# 先问是否有''直接寿命/健康寿命终点''。\n# 再问是否是''具体可干预节点''，而不是宽泛过程名。\n# 若宽泛过程没有终点证据，而具体节点有，则优先具体节点。","title":"mTOR/rapamycin)
【tool:write_note】
{"ok": true, "path": "/root/Sisyphus/wiki/tiddlers/mTOR_rapamycin_优先于泛化自噬_线粒体作为长寿候选.tid", "title": "mTOR/rapamycin 优先于泛化自噬/线粒体作为长寿候选"}
【assistant】
本轮结论：第三个高杠杆长寿瓶颈不应停留在“自噬/线粒体/蛋白稳态”这类宽泛过程名，而应先收敛到已经有**成年哺乳动物寿命终点**支持的具体节点——**mTOR/rapamycin**。
证据上，PubMed PMID **19587680**（Nature 2009）明确写到：**“Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.”**
相对地，我对 autophagy / mitochondrial 的泛题检索没有拿到同等级、可直接落到小鼠寿命终点的原始证据，因此它们目前更像“机制簇”，还不够资格直接当作主长寿瓶颈。
<NEXT_FOCUS>审计 rapamycin 在成年/老年哺乳动物中的寿命与健康寿命效应大小、起始年龄和代价，并判断它是否优于仅有机制热度的自噬/线粒体候选</NEXT_FOCUS>
========== REFLECTION ==========
{
"progress": "对蛋白稳态/自噬/线粒体候选做了第一轮证据筛选，但检索主要撞上空结果、综述和不相关的文献计量论文，尚未找到可直接支持长寿候选排序的原始干预证据。",
"failure": "用机制关键词做宽检索，容易把检索流量带进综述、bibliometric 或相关性文献，导致无法快速定位真正带寿命/健康寿命终点的原始研究。",
"lesson": {
"worthy": true,
"title": "候选筛选要用“干预 + 终点”双约束检索",
"tags": [
"lesson",
"method",
"principle",
"aging"
],
"text": "筛选长寿候选时，检索必须同时约束“可操纵的干预”和“寿命/健康寿命终点”；只搜机制词通常会淹没在综述、计量分析和相关性论文里，难以产生可排序的证据。"
},
"next_focus": "锁定一个成年哺乳动物中的原始干预研究，明确它是否同时满足“操纵自噬/蛋白稳态/线粒体”与“直接报告寿命或健康寿命终点”这两个条件。"
}